Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Feb;99(2):379-380.
doi: 10.1007/s00277-019-03846-0. Epub 2019 Dec 10.

Pyoderma gangrenosum induced by lenalidomide in a case of multiple myeloma

Affiliations
Case Reports

Pyoderma gangrenosum induced by lenalidomide in a case of multiple myeloma

Mathieu Meunier et al. Ann Hematol. 2020 Feb.
No abstract available

PubMed Disclaimer

References

    1. Kotla V, Goel S, Nischal S, Heuck C, Vivek K, Das B et al (2009) Mechanism of action of lenalidomide in hematological malignancies. J Hematol Oncol 2:36 - DOI
    1. Maverakis E, Ma C, Shinkai K, Fiorentino D, Callen JP, Wollina U, Marzano AV, Wallach D, Kim K, Schadt C, Ormerod A, Fung MA, Steel A, Patel F, Qin R, Craig F, Williams HC, Powell F, Merleev A, Cheng MY (2018) Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi consensus of international experts. JAMA Dermatol 154:461–466 - DOI
    1. Wang JY, French LE, Shear NH, Amiri A, Alavi A (2018) Drug-induced pyoderma gangrenosum: a review. Am J Clin Dermatol 19:67–77 - DOI
    1. Hu YQ, Yao XX, Zhang JZ, Li WH (2019) Penile pyoderma gangrenosum: successful treatment with thalidomide. Dermatol Ther 32(4):e12952
    1. Dasanu CA, Alexandrescu DT (2009) A case of severe aplastic anemia secondary to treatment with lenalidomide for multiple myeloma. Eur J Haematol 82:231–234 - DOI

MeSH terms